Local clinical trials are evaluating new treatments for people with type 1 diabetes. Take the two-minute screening survey today.

Tired of
Fighting the
Midnight Alarms?

Living with type 1 diabetes means your mind is always on duty. The constant vigilance required to avoid dropping dangerously low in your sleep carries … a heavy physical and emotional toll. Local clinical trials are currently evaluating an investigational approach for adults experiencing nocturnal hypoglycemia.

How Clinical
Trials Work

Clinical trials are the foundation of medical advancement. They are carefully monitored research studies designed to test new treatments to see if they are safe and effective. Participating in a clinical trial means not only exploring a new potential option, but also helping shape the future of T1D care for generations to come.

Here’s a look at what a clinical trial for Type 1 Diabetes might involve:

A principal investigator, or PI, is the physician in charge at a designated study site for the clinical trial who is responsible for coordinating and overseeing the clinical study. That individual carries out what is called a protocol.

A protocol is a document that describes how the trial is designed, and outlines how it should be carried out.

Clinical trials, also called research studies or clinical studies, can be either interventional, or non-interventional. Interventional studies mean that they test out an intervention, like a drug, procedure or medical device. Non-interventional studies, also called observational studies, don’t test potential treatments. Instead, researchers observe the participants over a period of time, and track health outcomes.

Clinical Trials Make a Difference

Participation in a clinical trial provides valuable information that could eventually lead to better treatments and — with the right advancements — to better outcomes. Take our short survey to see if you or a loved one may be a good fit. There is no obligation to enroll.

Understanding Type 1 Diabetes

WHAT IS IT?

Type 1 diabetes (T1D) often strikes unexpectedly. It is an autoimmune condition where the body’s immune system mistakenly attacks the beta cells in the pancreas that produce insulin. Insulin is an essential hormone that helps the body turn food into energy. T1D is not caused by diet or lifestyle.

For individuals without diabetes, the body automatically regulates blood sugar overnight. However, for those managing T1D, the insulin they take continues to work during sleep. If blood sugar drops too far, it causes nocturnal hypoglycemia (nighttime lows). Managing these overnight drops requires constant monitoring and frequent sleep interruptions, which is a significant and exhausting burden for those living with the condition.

HOW IS IT TREATED?

Treatment for T1D  requires a lifetime of monitoring, insulin therapy, and maintaining a healthy lifestyle, with a person effectively acting as their own pancreas around the clock. This means monitoring blood sugar levels, often through continuous glucose monitors or fingersticks, and administering external insulin via multiple daily injections or a wearable insulin pump. Currently, there is no cure for T1D.1

HOPE FOR THE FUTURE

Living with the anxiety of the nighttime lows  is deeply frustrating. By volunteering for clinical research, participants play a vital role in helping researchers understand how to better treat T1D.

Still Have Questions?

Contact us anytime at help@clinicalenrollment.com.